XML 35 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses    
Research and development expenses $ 74,091 $ 53,130
General and administrative 31,675 15,383
Total operating expenses 105,766 68,513
Operating loss (105,766) (68,513)
Other income and expense    
Loss on fair value adjustment to convertible SAFE Note   (530)
Other income (expense), net (9) (13)
Interest expense (137) (205)
Interest income 7,556 2,867
Accretion of discount on investments 23  
Total other income and expense 7,433 2,119
Loss from operations before income taxes (98,333) (66,394)
Net loss (98,333) (66,394)
Unrealized comprehensive loss on investments (103)  
Total other comprehensive loss (103)  
Comprehensive loss $ (98,436) $ (66,394)
Net loss per common share, basic $ (3.09) $ (12.4)
Net loss per common share, diluted $ (3.09) $ (12.4)
Weighted average number of shares outstanding used in computation of net loss per common share, basic 31,787,491 5,354,368
Weighted average number of shares outstanding used in computation of net loss per common share, diluted 31,787,491 5,354,368